# Castle Biosciences (CSTL) — News

CSTL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cstl/news

## Recent headlines

- [Castle Biosciences, - Opens new laboratory and office facility in Scottsdale, Arizona](https://www.ainvest.com/news/castle-biosciences-opens-laboratory-office-facility-scottsdale-arizona-2609) — AInvest Wire, Sep 22, 2026
  Castle Biosciences has announced the opening of a new laboratory and office facility in Scottsdale, Arizona. The expansion is part of the company’s strategy to enhance its operational capacity and support ongoing research and development efforts. The new location is expected to accommodate…
- [SCIBase receives additional order from Castle Biosciences, advancing the collaboration](https://www.ainvest.com/news/scibase-receives-additional-order-castle-biosciences-advancing-collaboration-2609) — AInvest Wire, Sep 8, 2026
- [Castle Biosciences to begin Nasdaq Texas listing today under CSTL](https://www.ainvest.com/news/castle-biosciences-nasdaq-texas-listing-today-cstl-2608) — AInvest Wire, Aug 17, 2026
- [Castle Biosciences approved for dual listing on Nasdaq Texas](https://www.ainvest.com/news/castle-biosciences-approved-dual-listing-nasdaq-texas-2608) — AInvest Wire, Aug 17, 2026
  Castle Biosciences, Inc. (Nasdaq: CSTL) has been approved for a dual listing of its common stock on Nasdaq Texas, LLC, effective August 17, 2026. The company's common stock, which is already listed on The Nasdaq Global Market, will now also trade on Nasdaq Texas under the same ticker symbol "CSTL".…
- [Castle Biosciences Q2 pretax profit USD -1.69 million](https://www.ainvest.com/news/castle-biosciences-q2-pretax-profit-usd-1-69-million-2607) — AInvest Wire, Jul 30, 2026
  Castle Biosciences (Nasdaq: CSTL) reported a pretax loss of USD -1.69 million for the second quarter of 2025, reflecting ongoing financial challenges in its operations during the period. The company, which specializes in precision diagnostics for dermatologic and gastroenterological diseases,…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).